Statistics for Zentalis Pharmaceuticals (id:6460 ZNTL)

Valuation metrics

Market cap

263.81M

Enterprise value

-118,547,440.00

Trailing P/E (ttm)

-0.72

Forward P/E

-1.04

PEG ratio

-1.04

Price/Sales (ttm)

6.50

Price/Book (mrq)

0.69

Enterprise Value/Revenue

-2.92

Enterprise Value/EBITDA

0.54

Overview

Shares outstanding

71.11M

Float

50.95M

Shares short

7.66M

% Held by insiders

0.03%

% Held by institutions

1.03%

Average volume (10 days)

1.79M

Average volume (90 days)

Price summary

52-Week low

2.66

52-Week high

18.07

52-Week change

-235.91%

Beta

1.74

50-Day moving average

3.38

200-Day moving average

8.07

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-543.77%

Operational effectiveness

Return on assets

-24.77%

Return on equity

-42.99%

Income statement

Revenue (ttm)

0.57

Revenue per share (ttm)

0.57

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-219,216,992.00

Net income to common (ttm)

-194,654,000.00

Diluted EPS (ttm)

-2.64

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

426.38M

Total cash per share (mrq)

6.00

Total debt (mrq)

44.03M

Total Debt/Equity (mrq)

11.51

Current ratio (mrq)

659.20%

Book value per share (mrq)

5.38

Cash flow

Cash flow statement

-166,376,992.00

Levered free cash flow (LFCF)

-71,432,624.00